Venture capital firm with a history of investing in transformative technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Harvey | 2025 | Series F | $160.0M | San Francisco |
| Synthesia | 2025 | Series E | $200.0M | London |
| Rapt Therapeutics | 2025 | Post Ipo Equity | $250.0M | South San Francisco |
| NewLimit | 2025 | Convertible Note | $45.0M | South San Francisco |
| Lit Protocol | 2025 | Series Unknown | Undisclosed | San Francisco |
| LuxCreo Inc. | 2025 | Corporate Round | Undisclosed | Belmont |
| M.AI Unbound, Inc | 2025 | Seed | $25.0M | Mountain View |
| Inngest | 2025 | Series A | $21.0M | San Francisco |
| Keplar | 2025 | Seed | $3.4M | San Francisco |
| Convoke | 2025 | Seed | $8.6M | South San Francisco |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Harvey | Series F | $160.0M | San Francisco, United States |
| 102 | Synthesia | Series E | $200.0M | London, United Kingdom |
| 103 | Rapt Therapeutics | Post Ipo Equity | $250.0M | South San Francisco, United States |
| 104 | NewLimit | Convertible Note | $45.0M | South San Francisco, United States |
| 105 | Lit Protocol | Series Unknown | Undisclosed | San Francisco, United States |
| 106 | LuxCreo Inc. | Corporate Round | Undisclosed | Belmont, United States |
| 107 | M.AI Unbound, Inc | Seed | $25.0M | Mountain View, United States |
| 108 | Inngest | Series A | $21.0M | San Francisco, United States |
| 109 | Keplar | Seed | $3.4M | San Francisco, United States |
| 110 | Convoke | Seed | $8.6M | South San Francisco, United States |
Harvey provides AI-driven tools to assist legal professionals with research, document review, and contract analysis.
Synthesia is an AI video platform that enables users to create videos from text using advanced AI avatars and voiceovers.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
Lit Protocol is decentralized access control infrastructure designed to bring more utility to the web.
LuxCreo invented the first full-stack, FDA Class II 510(k) cleared additive platform to transform the dental clear aligner industry.
Unified AI Agent built for Marketers
Inngest is the developer platform for easily building reliable workflows with zero infrastructure.
Keplar Voice is an AI-powered market research platform that enables organizations to conduct, natural voice conversations with customers.
Convoke is curating high-quality datasets, automating workflows, and building a software platform.
SpinLaunch is a space technology company revolutionizing how we access and operate in space.
Motive is a fleet management and driver safety platform that helps improve the safety, productivity, and profitability of fleet operations.
Ambience Healthcare develops an AI operating system used for documentation, coding, and clinical workflows in healthcare organizations.
Farmers Business Network is a digital marketplace that helps farmers buy inputs, access financing, and join marketing programs.
Nav is a credit and financial health platform that provides access to credit and financing opportunities for businesses.
Superblocks is a software company that offers UI templates, AI interfaces, and generative app services.
Stord is a commerce enablement platform that operates a distributed fulfillment network for various brands across multiple channels.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Rippling is a workforce management platform that unifies HR, IT, and finance operations into a single system.
With operations and projects in the US and Brazil, Terradot is the leading Enhanced Rock Weathering carbon removal platform.
Omnifold is a software company that focuses on developing AI-powered supply chain software to deliver self-improving forecasting algorithms.
Persona is an identity verification and management platform that enables businesses to automate and streamline their verification processes.
Browserbase is a comprehensive platform for developers to host, administer, and monitor headless browsers in the cloud.
Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.
Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.
Kleiner Perkins has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Kleiner Perkins's top investment sectors include Software, Artificial Intelligence (AI), Information Technology, Health Care, SaaS. The firm invests across 59 different industry categories.
Among tracked funding rounds, Transcarent received $481.0M in a Series D round. Kleiner Perkins's total known invested capital is $12.8B.
Kleiner Perkins's average investment size is $62.4M across its portfolio of 279 companies.
Recent Kleiner Perkins portfolio additions include Harvey, Synthesia, Rapt Therapeutics, NewLimit, Lit Protocol. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors